Daiwa Securities Group Inc. boosted its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 9.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 115,387 shares of the company's stock after acquiring an additional 9,596 shares during the period. Daiwa Securities Group Inc.'s holdings in Colgate-Palmolive were worth $10,490,000 at the end of the most recent quarter.
A number of other hedge funds also recently bought and sold shares of CL. Kohmann Bosshard Financial Services LLC acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth about $26,000. Centricity Wealth Management LLC acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth about $27,000. Union Bancaire Privee UBP SA acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth about $32,000. OFI Invest Asset Management acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth about $36,000. Finally, Bernard Wealth Management Corp. acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth about $36,000. 80.41% of the stock is currently owned by institutional investors.
Colgate-Palmolive Price Performance
NYSE:CL opened at $94.05 on Wednesday. The firm has a market cap of $76.32 billion, a PE ratio of 26.72, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a 12 month low of $85.32 and a 12 month high of $109.30. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The company's 50-day moving average price is $89.03 and its two-hundred day moving average price is $94.99.
Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period last year, the firm earned $0.87 EPS. On average, equities analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Several equities analysts recently weighed in on the company. Morgan Stanley cut their price objective on Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating for the company in a research report on Monday, February 3rd. Barclays cut their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating for the company in a research report on Friday, January 17th. JPMorgan Chase & Co. decreased their target price on Colgate-Palmolive from $103.00 to $97.00 and set an "overweight" rating on the stock in a research report on Monday, February 3rd. Wells Fargo & Company decreased their target price on Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating on the stock in a research report on Tuesday, January 7th. Finally, Stifel Nicolaus decreased their target price on Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating on the stock in a research report on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat, Colgate-Palmolive presently has a consensus rating of "Moderate Buy" and an average target price of $101.61.
Check Out Our Latest Report on Colgate-Palmolive
Colgate-Palmolive Company Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.